These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27376944)

  • 1. Efficacy of rabbit antithymocyte globulin as first-line treatment of severe aplastic anemia: an Asian multicenter retrospective study.
    Chuncharunee S; Wong R; Rojnuckarin P; Chang CS; Chang KM; Lu MY; Hwang WL; Koh LP; Chen TY; Leung AY; Norasetthada L; Wang SC; Chang MC; Wu KH; Issaragrisil S
    Int J Hematol; 2016 Oct; 104(4):454-61. PubMed ID: 27376944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study.
    Shin SH; Yoon JH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Park CW; Lee JW
    Ann Hematol; 2013 Jun; 92(6):817-24. PubMed ID: 23318980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia.
    Atta EH; Lima CBL; Dias DSP; Clé DV; Bonduel MM; Sciuccati GB; Medeiros LA; Oliveira MM; Salvino MA; Garanito MP; Blum Fonseca PB; Saad STO; Calado RT; Scheinberg P
    Ann Hematol; 2017 Nov; 96(11):1907-1914. PubMed ID: 28815305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia.
    Hayakawa J; Kanda J; Akahoshi Y; Harada N; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Kimura SI; Kikuchi M; Yamazaki R; Kako S; Kanda Y
    Int J Hematol; 2017 May; 105(5):578-586. PubMed ID: 28078653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rabbit antithymocyte globulin dose does not affect response or survival as first-line therapy for acquired aplastic anemia: a multicenter retrospective study.
    Clé DV; Atta EH; Dias DSP; Lima CBL; Bonduel M; Sciuccati G; Medeiros LA; de Oliveira MM; Blum Fonseca PB; Saad STO; Hamerschlak N; Salvino MA; Garanito MP; Pazin-Filho A; Scheinberg P; Calado RT
    Ann Hematol; 2018 Nov; 97(11):2039-2046. PubMed ID: 29978284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rabbit antithymocyte globulin treatment in childhood acquired severe aplastic anemia.
    Karapinar DY; Karadaş N; Ay Y; Akin M; Balkan C; Aydinok Y; Kavakli K
    Pediatr Hematol Oncol; 2014 Feb; 31(1):20-8. PubMed ID: 23627541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified immunosuppressive therapy with porcine antilymphocyte globulin plus delayed cyclosporine A in children with severe aplastic anemia.
    Cui Q; Sha P; Chen H; Shen H; Qin L; Li Z; Wu T; Wang Z
    Int J Hematol; 2018 Jan; 107(1):64-68. PubMed ID: 28900860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children.
    Jeong DC; Chung NG; Cho B; Zou Y; Ruan M; Takahashi Y; Muramatsu H; Ohara A; Kosaka Y; Yang W; Kim HK; Zhu X; Kojima S
    Haematologica; 2014 Apr; 99(4):664-71. PubMed ID: 24213150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia.
    Scheinberg P; Nunez O; Weinstein B; Scheinberg P; Biancotto A; Wu CO; Young NS
    N Engl J Med; 2011 Aug; 365(5):430-8. PubMed ID: 21812672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: a single-center retrospective study.
    Atta EH; Dias DS; Marra VL; de Azevedo AM
    Ann Hematol; 2010 Sep; 89(9):851-9. PubMed ID: 20373101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-line immunosuppressive therapy with rATG and CsA for severe aplastic anemia: 15 years' experience.
    Hu J; Zhang L; Zhao X; Liu X; Jing L; Zhou K; Li Y; Li Y; Li J; Ye L; Peng G; Fan H; Yang W; Yang Y; Xiong Y; Song L; Zhang F
    Ann Hematol; 2022 Nov; 101(11):2405-2412. PubMed ID: 36151352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
    Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
    Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Porcine antilymphocyte globulin (p-ALG) plus cyclosporine A (CsA) treatment in acquired severe aplastic anemia: a retrospective multicenter analysis.
    Wei J; Huang Z; Guo J; Zhang Y; Wang C; Zhu X; Zhang Y
    Ann Hematol; 2015 Jun; 94(6):955-62. PubMed ID: 25666078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of 172 children with severe aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine.
    Lan Y; Chang L; Yi M; Cai Y; Feng J; Ren Y; Liu C; Chen X; Wang S; Guo Y; Zhang A; Liu L; Zhang J; Zhu X
    Ann Hematol; 2021 Jan; 100(1):53-61. PubMed ID: 33033910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Horse versus rabbit antithymocyte globulin in immunosuppressive therapy of treatment-naïve aplastic anemia: a systematic review and meta-analysis.
    Yang N; Chen J; Zhang H; Dai Z; Yao H; Ma X; Bai J; Zhang Y; Zhang W
    Ann Hematol; 2017 Dec; 96(12):2031-2043. PubMed ID: 28965225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective randomized trial comparing two doses of rabbit anti-thymocyte globulin in patients with severe aplastic anaemia.
    Narita A; Zhu X; Muramatsu H; Chen X; Guo Y; Yang W; Zhang J; Liu F; Jang JH; Kook H; Kim H; Usuki K; Yamazaki H; Takahashi Y; Nakao S; Wook Lee J; Kojima S;
    Br J Haematol; 2019 Oct; 187(2):227-237. PubMed ID: 31206607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different outcomes between cyclophosphamide plus horse or rabbit antithymocyte globulin for HLA-identical sibling bone marrow transplant in severe aplastic anemia.
    Atta EH; de Sousa AM; Schirmer MR; Bouzas LF; Nucci M; Abdelhay E
    Biol Blood Marrow Transplant; 2012 Dec; 18(12):1876-82. PubMed ID: 22796534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination of rabbit antithymocyte globulin and cyclosporine A as first-line therapy for adult severe aplastic anemia].
    Cao HM; Wang HJ; Zhang L; Jing LP; Zhou K; Yang DL; Li HQ; Liu QG; Yan ZS; Liu YZ; Wu YH; Chu YL; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):38-42. PubMed ID: 21429400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early intensified intravenous cyclosporine therapy predicts favorable response to immunosuppressive therapy with rabbit antithymocyte globulin in patients with severe aplastic anemia.
    Song MK; Chung JS; Joo YD; Lee GW; Hong J; Park SH; Shin HJ
    Leuk Res; 2015 Mar; 39(3):284-9. PubMed ID: 25563075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.